TBI remained significantly associated with reduced adjusted risks of grade 3 to 4 aGVHD and moderate-severe cGVHD.

Acute Myeloid Leukaemia (AML) with Retinoic acid receptor-gamma (RARG) fusions have similarities to Acute Promyelocytic Leukemia (APL) but are not responsive to standard APL treatments.

Monocytopenia describes a low number of monocytes, a type of white blood cell. Monocytes are made in the bone marrow and account for 2% to 6% of white blood cells at any given time. They work ...

for the treatment of acute myeloid leukemia (“AML”). Fast Track designation is a process designed to streamline the development and accelerate the assessment of drugs that target serious conditions ...

Researchers determine whether mutations in the Omicron NTD influence its potential to stimulate myeloid cells and enhance ... defeating chronic myelogenous leukemia, which tends to affect older ...

Venetoclax (Brand name: Venclexta) is a targeted treatment for chronic lymphocytic leukemia (CLL). It targets a specific protein called BCL-2 in cancer cells that helps them stay alive. Doctors ...

Our innovations in this area include a low-cost method of testing for chronic myeloid leukemia, a blood cancer, using a drop of blood on a paper card. Through a Fred Hutch partnership with the Max ...

These include advances in the understanding of the molecular genetics and pathophysiology of the disease, the possibility of testing measurable residual disease (MRD), the improvement of risk-adapted ...

Myeloproliferative neoplasms are blood cancers that affect myeloid stem cells. Treatment can involve targeted medications or careful monitoring. Myeloproliferative disorders are a group of cancers ...

These cancers include esophageal carcinoma (ESCA), gastric cancer (GC), glioma, laryngeal squamous cell carcinoma (LSCC), acute myeloid leukemia (AML), lung adenocarcinoma (LUAD), nasopharyngeal ...

Blood Cancer Discovery provides a critical outlet for high-impact basic, translational, and clinical research on all disease subtypes of leukemia, lymphoma, myeloma, and associated diseases. Read More ...

Once the dilated colon is identified, the clinician must assess the severity of the patient's condition. Patients who appear clinically stable should be treated conservatively. In general, the ...